baber/WOPTO huggingface dataset:
Patent IL-110417-A0 (IL)
Title: Lunchbox
IPC: A45C13/00
Filed: 1994-07-22
Abstract: A lunchbox (10) including a lid (14) and base (12) pivotally engaged by snap together hinge assemblies (40) and including a pivotal latch assembly (64) and a separate lock assembly (98). The lock assembly includes a pair of locking collars (100) on the pivoting handle (16) on the base (12) which engage a pair of lugs (106) on the lid (12) with withdrawal of the lugs being prevented in the carrying position of the handle. <IMAGE>
Patent IL-115742-A0 (IL)
Title: Pharmaceutical compositions comprising a difficultly soluble active agent
Inventor: COTTENS SYLVAIN
IPC: A61P37/06
Filed: 1995-10-24
Abstract: This invention provides a microemulsion pre-concentrate comprising a difficultly soluble agent and a carrier medium comprising: 1) a hydrophilic phase which comprises dimethyisosorbide and/or a lower alkyl alkanoic ester, 2) a lipophilic phase, and 3) a surfactant. The active agent may be a cyclosporine or a macrolide. In another aspect, this invention provides a pharmaceutical composition for enteral or parenteral administration comprising a macrolide and an acid.
Patent IL-130162-A0 (IL)
Title: Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
IPC: C12N15/09
Filed: 1997-12-12
Abstract: A synthetic nuclease resistant antisense oligodeoxynucleotide (AS-ODN) capable of selectively modulating human acetylcholinesterase (AChE) production and a composition comprising at least one AS-ODN as an active ingredient. A nuclease resistant antisense targeted against the splice junction in the AChE mRNA post-splice message is disclosed. The synthetic nuclease resistant AS-ODNs are capable of selectively modulating human AChE production in the central nervous system or capable of selectively reducing human AChE deposition of the neuromuscular junction. The present invention also provides a method to restore balanced cholinergic signalling in the brain and spinal cord or reduce AChE in the neuromuscular junction in patients in need of such treatment by administering to a patient in need of such treatment a therapeutically effective amount of at least one of the synthetic nuclease resistant AS-ODN capable of selectively modulating human AChE production.
Patent IL-143569-A0 (IL)
Title: A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
IPC: A61K31/675
Filed: 1999-12-22
Abstract: Pharmaceutical compositions containing an FBPase inhibitor and an insulin sensitizer are provided as well as methods for treating diabetes and diseases responding to increased glycemic control, an improvement in insulin sensitivity, a reduction in insulin levels, or an enhancement of insulin secretion.
Patent IL-151990-A0 (IL)
Title: Milk sampling apparatus and method
IPC: G01N1/18
Filed: 2001-03-28
Abstract: Example embodiments of the present invention refer to a milk sampling apparatus and method for use with an automated milking system. The apparatus comprises a cassette ( 7 ) wherein milk sample collecting elements ( 9 ) are placed, and at least one filling member ( 27 ) capable of being placed above a selected one of the milk sample collecting elements ( 9 ) by a positioning system, and capable of bringing a milk sample, representatively taken from milk yielded during the milking of an animal by the automated milking system, into the selected one of the milk sample collecting elements ( 9 ). The positioning system comprises an arm ( 34 ) extending in a first dimension (Y) in a plane (XY) above the milk sample collecting elements ( 9 ) and being movable in a second direction (X) in the plane (XY), the first (Y) and second (X) directions being orthogonal; a runner ( 32 ) holding the filling member ( 27 ) and being movable along the arm ( 34 ); and first ( 29 ) and a second ( 31 ) drives, wherein the first drive ( 29 ) is effective to move the arm ( 34 ) and the second drive ( 31 ) is effective to move the runner ( 32 ) such that filling member ( 27 ) is positioned above the selected one of the milk sample collecting elements ( 9 ).
Patent IL-158762-A0 (IL)
Title: Prevention of addiction in pain management
IPC: A61K31/165
Filed: 2002-04-08
Abstract: The present invention provides a composition for treating pain. The composition includes a pharmaceutically acceptable analgesic and a GABAergic agent, such as gamma vinyl GABA, effective in reducing or eliminating the addictive liability of the analgesic. The invention also includes a method for reducing or eliminating the addictive
Patent IL-164275-A0 (IL)
Title: Pharmaceutical compositions containing carbon-2-modified-viatimin d analogs
IPC: A61C8/00
Filed: 2003-03-12
Abstract: It has been discovered that the 2-carbon-modified derivatives of 1α,25-dihydroxyvitamin D3 specifically stimulate osteoblasts to form new bone. The ability of the 2-carbon-modified vitamin D analogs to stimulate new bone formation suggest that these compounds can be used where synthesis of new bone is required. Thus, these compounds can be used either systemically or locally to stimulate the growth of bone transplants, to increase the rate of fracture healing and thereby reduce the time required for the healing of fractures, the stimulation of bone growth when required for replacement surgery, and also for the growth of bone to implants or other devices required to maintain the skeleton or teeth in the proper positions.
Patent IL-182034-A0 (IL)
Title: Substituted chroman derivatives, medicaments and use in therapy
Filed: 2007-03-20
Abstract: Novel substituted chroman derivatives and intermediate compounds, composition containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
Patent IL-189183-A0 (IL)
Title: Novel indole compounds
Filed: 2008-02-03
Abstract: Indole derivatives (I), are new. Indole derivatives of formula (I) and their salts are new. R a, R bH, halo, 1-6C alkyl, CF 3, CN, COR 2, OR 2 or phenyl (optionally substituted by 1-4C alkyl or CF 3); R 21-4C alkyl, CF 3 or phenyl (optionally substituted by 1-4C alkyl or CF 3); R 2H or 1-4C alkyl; R : H or 1-3C alkyl; n : 1-3; X : a bond or O, and Ar 1phenyl, naphthyl, quinolinyl, isoquinolinyl, pyridinyl, pyrazolyl, imidazolyl, isoxazolyl, thiazolyl, benzothiazolyl, 2,1,3-benzothiadiazolyl, 3,4-dihydro-1,4-benzoxazinyl, 5,6,7,8-tetrahydronaphthlaneyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydro-2-oxoquinolinyl, 3,4-dihydro-2H-benzopyranyl, indolyl, 2,3-dihydroindolyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, 1,4-benzodioxanyl or benzoxazolyl (all optionally substituted by halo, 1-6C alkyl, CF 3, CN, CO-R 2, OR 2, NH-COR 2, morpholinyl, amino or 4-morpholinosulfonyl). Independent claims are included for the preparation of (I). [Image] ACTIVITY : Antilipemic; Antidiabetic; Cardiovascular-Gen.; Antiinflammatory; Neuroprotective; Nootropic; Antiparkinsonian; Anorectic; Antiarteriosclerotic; Cardiant; Hypotensive; Antiarthritic; Antirheumatic. MECHANISM OF ACTION : Peroxisome proliferator activated receptor (PPAR) activator. In a test used to determine activation of PPAR-alpha and/or PPAR-gamma , results showed that (I) exhibited an EC 50 value of 50 nM.
Patent IL-194521-A0 (IL)
Title: Load control device having a variable drive circuit
Filed: 2008-10-05
Abstract: A load control device for controlling the amount of power delivered to an electrical load from a source of AC power comprises a controllably conductive device and a variable gate drive circuit. The controllably conductive device is coupled in series electrical connection between the source and the electrical load to control the amount of power delivered to the load. The variable drive circuit is thermally coupled to the controllably conductive device and provides a continuously variable impedance in series with the control input of the controllably conductive device. The impedance of the variable drive circuit is operable to decrease as a temperature of the controllably conductive device increases and vice versa. Preferably, the variable drive circuit comprises an NTC thermistor. Accordingly, the switching times of the controllably conductive device, i.e., the times when the controllably conductive device is changing between the conductive and non-conductive states, remain constant, or alternatively decrease, as the temperature of the controllably conductive device increases.
Patent IL-198670-A0 (IL)
Title: Conformable track assembly for a robotic crawler
Filed: 2009-05-10
Abstract: A suspension system (10) for a lightweight robotic crawler is disclosed. The suspension system provides for mounting of a flexible endless track (18) thereon. The suspension system includes a forward guide (14) and a rearward guide (16) around which the endless track can be looped. A deflector (20) positioned between the forward guide and the rearward guide downwardly deflects a ground-engaging portion of the endless track to form a peaked area (24). The peaked area can support the lightweight robotic vehicle allowing alteration of a distribution of load over the ground-engaging portion of the endless track with respect to a supporting surface.
Patent IL-211005-A0 (IL)
Title: Method and apparatus for manufacture of a polymer film, which is oriented under an angle to its longitudinal direction
Filed: 2011-02-02
Abstract: Flexible tubular film (10) is helically cut into a flat strip by unwinding the tubular film in flattened form by a tumbling unwinder (1), advancing the flat film tube to a tube expansion zone (17) in which the flat tube is expanded into a circular cylindrical tube and is passed axially over a hollow mandrel (14) slightly lower in external diameter than the diameter of the expanded tube to be cut by knife (18) helically while on the mandrel into a flat strip that is removed at an angle to the mandrel axis. The flat tube is longitudinally stretched by stretching rollers (107-112), which tumble with the tumbling unwinder. The apparatus further comprises stabilization means for stabilizing the orientation applied by the tumbling stretching rollers, applied to the helically cut film strip after it has been drawn from the mandrel.
Patent IL-219163-A0 (IL)
Title: A process for the preparation of optically active chiral amines
Filed: 2012-04-15
Abstract: The present invention relates to the production of optically pure secondary amines, which can be used as intermediate products in a synthesis of for instance pharmaceutical products.
Patent IL-227752-A0 (IL)
Title: Polymer conjugates of mutated neublastin
IPC: A61K47/48
Filed: 2013-08-01
Abstract: A dimer comprising a mutated neublastin polypeptide coupled to a polymer is disclosed. Such dimers exhibit prolonged bioavailability and, in preferred embodiments, prolonged biological activity relative to wild-type forms of neublastin.
Patent RO-126316-A0 (RO)
Title: Disc extractor for recovering petroleum products or the like from water surface
Inventor: STATE GEORGE
IPC: E02B15/04
Filed: 2010-11-05
Abstract: The invention relates to a disc extractor meant to recover petroleum products or the like from water surface. According to the invention, the extractor comprises a main bed frame (1) on which there is mounted a motor (2) driving a main shaft (5) on which there are mounted some extracting discs (11), wherebetween some double trough-scrapers (15) are placed on a fixed support plate (12) or some left trough-scrapers (23) are placed on a mobile left plate (20), while some right simple trough-scrapers (24) are placed on a mobile right support plate (21).
Patent RO-131798-A0 (RO)
Title: Method for elimination of criticalness in complex network ventilation constructions
Inventor: CIOCLEA DORU
IPC: E21F9/00
Filed: 2016-11-25
Abstract: The invention relates to a method for eliminating criticalness related to ventilation constructions in complex networks, which may be applied in any underground mine works for exploitation of useful mineral substances. According to the invention, the method consists, in a first stage, in modelling, solving and optimizing a ventilation network under normal working conditions, followed by setting the operational parameters of an active ventilator, then setting the influence zones specific for each main ventilation station, after which the influence of ventilation constructions upon the active ventilators operating stability is established and the critical ventilation constructions are identified; further on, the elimination of criticalness of the ventilation construction is initiated by reducing the total resistance generated by achieving a parallel connection with the branch on which the critical construction is placed and on which a ventilation construction of equivalent resistance is positioned, and the effect of this method on the operational parameters of the main ventilation station is established, after which the criticalness of the ventilation construction is finally eliminated by dispersing the total resistance generated by its disposal upstream or downstream the branch on which the critical construction is placed and on which a ventilation construction with equivalent resistance is placed, and the effect of this method upon the ventilation station operational parameters is established.
Patent RO-137276-A0 (RO)
Title: Multivalent toothpaste composition with β-cyclodextrin inclusion complex with clove essential oil
Inventor: MITITELU MAGDALENA
IPC: A61K6/69
Filed: 2022-10-25
Abstract: The invention relates to a toothpaste composition with natural active principles intended for oral hygiene, having a remineralising, antimicrobial, antifungal, anti-inflammatory, immunomodulatory, soothing, healing, tartar-reducing action with xylitol and tooth-enamel whitening action with sodium bicarbonate. According to the invention, the toothpaste composition consists of the association of 96% glycerin with sodium carboxymethyl cellulose, propylene glycol, deionized water, sodium bicarbonate, calcium carbonate, coconut tenside, xylitol, β-cyclodextrin inclusion complex with clove essential oil, myrrh essential oil, laurel essential oil, rosemary essential oil, tea tree essential oil, in the following association ratio expressed as parts by weight: 16...18 : 0.9...1.1 : 5 ...10 : 23.5...28.5 : 0.4...0.5 : 37...39 : 0.5...0.6 : 3...3.5 : 0.8 ...1 : 0.8...1 : 0.8...1 : 0.8...1 : 0.8...1.
Patent MC-1475-A1 (MC)
Inventor: SCHAEFFER HOWARD JOHN
IPC: C07D473/16
Filed: 1982-08-10
Abstract: Compounds of the general formula <CHEM> (wherein R is a hydroxy or amino group and X is an oxygen or sulphur atom) and their physiologically acceptable salts and esters have been known to have antiviral activity particularly against herpes viruses. Processes for preparing such compounds are described as well as pharmaceutical and veterinary compositions containing these compounds.
Patent AT-523509-A1 (AT)
Title: Therapiebett
Inventor: FRANZ KUTSCHI ING
IPC: A61G7/057
Filed: 2020-01-15
Abstract: Die vorliegende Erfindung betrifft ein Therapiebett (1) für Patienten mit eingeschränkter Mobilität, umfassend ein Bettgestell (16), mit mindestens zwei Säulen (2) mit einer Kugellagerung, oder einem Kippmechanismus oder mit einer Ringlagerung für ein Rollentraggestell, sowie einer schwenk - oder kippbaren Patientenunterstützung (8) mit Stützelementen (10). Erfindungsgemäß ist vorgesehen, dass das Therapiebett (1) aus einem Bettgestell (16) mit mindestens vier an den Säulen (2) angeordneten elektrischer Linearantriebe (14) und Linearschlitten (3) mit fest verbundenen Gelenkköpfen (4), sowie aus einer Patientenunterstützung (8), mit vier fest verbundenen Gelenkköpfen (6), und den steckbaren Stützelementen(10) besteht, wobei die Patientenunterstützung (8) mit mindestens vier elektrischer Linearantriebe (11) in den Gelenkköpfen (4) und (6) mit dem Bettgestell (16) beweglich verbunden ist. Dadurch entsteht der erfindungsgemäße Vorteil, dass die Patientenunterstützung flexibel die Seitenlagen sowie eine Trendelenburg Lagerung einnehmen kann und in den Höhen Verstellbar ist.
Patent MA-20581-A1 (MA)
IPC: C07D333/22
Filed: 1985-11-28
Abstract: 3-oximino diphenyl ether derivatives having the general formula:-   <CHEM> wherein n is 1, 2 or 3 and each group A, which may be the same or different when n is greater than 1, represents a halogen atom or a cyano, nitro, alkyl or haloalkyl group; Z represents a halogen atom or a nitro or cyano group; and X and Y, which may be the same or different, each independently represents a hydrogen or halogen atom or an alkyl, cycloalkyl, haloalkyl, alkoxy, alkylthio, acyl, or optionally substituted aryl or heteroaromatic group, or one of X and Y represents one of such groups and the other represents a cyano, carboxyl, alkoxycarbonyl, phosphonic ester or alkylamino group, or X and Y together with the interjacent carbon atom may jointly represent a cycloalkyl group. The preparation of such compounds, Herbicidal compositions containing them and their use as herbicides.
Patent MA-24459-A1 (MA)
IPC: A01H15/00
Filed: 1998-01-26
Abstract: The invention concerns intraspecific hybrids of Agaricus bisporus capable of bearing fruit at relatively high temperature and without roughing-in, and the method for obtaining them consisting in a step of cross-breeding in particular between a first and a second Agaricus bisporus, one of which at least belongs to the burnettii variety, and a step of selecting the resulting hybrids having the characteristics mentioned above. The cultivation of the resulting hybrids is easier and less expensive than the standard method of cultivating mushrooms.
Patent MA-28174-A1 (MA)
Title: Utilisation d'inhibiteurs de cathepsine k dans des maladies de la perte osseuse severe
Inventor: MISSBACH MARTIN
IPC: A61K31/495
Filed: 2006-05-24
Abstract: De manière générale, la présente invention a trait à des inhibiteurs de cathepsine K et à leur utilisations dans la croissance osseuse. De manière spécifique, la présente invention a trait à l'utilisation d'inhibiteurs de cathepsine K pour la stimulation de nouvelle formation osseuse chez des patients qui en ont besoin.
Patent MA-38246-A1 (MA)
Title: Compositions pesticides et leurs procédés associés
Inventor: PATNY AKSHAY
IPC: A01N25/26
Filed: 2015-07-08
Abstract: L'invention concerne des molécules ayant la formule suivante (« formule un ») et leurs procédés associés.
Patent MA-38602-A1 (MA)
Title: Procédé de production de biodiesel à partir des huiles végétales ou animales au moyen de catalyseurs solides phosphatés à structure apatitique sous forme de poudres ou extrudés
Inventor: ZAHOUILY MOHAMED
IPC: C11C1/06
Filed: 2015-11-17
Abstract: Le domaine de la présente invention est celui de la fabrication du biocarburant. Elle consiste à synthétiser des esters alcooliques d'acides gras à partir d'huiles végétales ou animales par une réaction de transestérification en utilisant un catalyseur de type phosphate de structure apatite d'origine naturel ou synthétique.
Patent UY-24312-A1 (UY)
Title: Procedimiento para preparar derivados tetracíclicos que son inhibidores potentes y selectivos de la fosfodiesterasa específica del 3', 5'-monofosfato de guanosina cíclico.
IPC: A61P9/04
Filed: 1996-08-20
Abstract: Se describe un proceso (A) para la preparación de un compuesto de fórmula (I) (figura 1) y los solvatos del mismo, caracterizado porque R2 representa el anillo bicíclico (figura 2). El proceso comprende el reaccionar un compuesto de la fórmula (II) (figura 3) en un solvente apropiado tal como un alcohol (por ejemplo metanol o etanol) o una mezcla de solventes, convenientemente a una temperatura de 20ºC hasta la temperatura de reflujo (por ejemplo hasta aproximadamente 50ºC). Como ejemplo no limitante del compuesto: (6R, 12aR)-2,3,6,7,12,12a-hexahidro-6-(5-benzofuranil)-2-metil-pirazino[2',1':6,1]pirido[3,4-b]indol-1,4-diona. Los compuestos de fórmula (I) tienen utilidad en el tratamiento de un número de desórdenes, incluyendo angina estable, inestable y variante, hipertensión pulmonar, insuficiencia cardíaca congestiva, entre otros.
Patent UY-25141-A1 (UY)
Title: Extraccion hidrometalurgica de metales
Inventor: JONES DAVID L
IPC: C22B47/00
Filed: 1998-08-14
Abstract: UN PROCEDIMIENTO PARA LA EXTRACCIÒN DE COBRE A PARTIR DE UNA MENA O CONCENTRADO DE COBRE SULFÚRICO QUE COMPRENDE LAS SIGUIENTES ETAPAS: SOMETER LA MENA A OXIDACIÓN CON PRESIÓN EN PRESENCIA DE OXIGENO Y UNA SOLUCION ÁCIDA CONTENIENDO IONES DE HALURO Y SULFATO; LIXIVIAR LA SAL BÁSICA DESULFATO DE COBRE PRODUCIDA MEDIANTE LA OXIDACION CON PRESION EN UNA LIXIVIACION CON UNA SOL. áC. DE SULFATO; SEPARAR EL LICOR DE LIXIVIACIóN DEL RESIDUO SÓLIDO; SOMETER EL LICOR DE LIXIVIACIÓN A UN PROCEDIMIENTO DE EXTRACCIÓN CON DISOLVENTE; RECICLAR POR LO MENOS UNA PORCIÓN DEL REFINADO A LA OXIDACIÓN CON PRESIÓN. La suspensión es sometida a una etapa de separación liquido/sólido para obtener un filtrado resultante de oxidación con presión y un residuo sólido conteniendo una sal básica de sulfato metálico insoluble. La sal básica de sulfato metálico es lixiviada en una segunda etapa de lixiviación con una solución ácida de sulfato para disolver la sal básica metálica para producir un licor de lixiviación conteniendo un sulfato metálico, por ejemplo sulfato de cobre en la solución y un residuo sólido final. El licor de lixiviación es separado del residuo sólido y sometido a un procedimiento de extracción con disolvente para producir una solución metalica concentrada y un refinado con el metal agotado. Por lo menos una porción del refinado es reciclada a la oxidación con presión.
Patent UY-26555-A1 (UY)
Title: Composición farmacéutica para modulación inmunológica y preparación de vacunas
Inventor: LINGNAU KAREN
IPC: A61P37/04
Filed: 2001-01-24
Abstract: La invención describe una composición farmacéutica que comprende un antígeno, un CpG-ODN inmunogénico y un polímero catiónico.
Patent UY-27050-A1 (UY)
Title: Nuevos derivados de ácido mandelico y su uso como inhibidores de trombina
Inventor: TORD INGHARDT
Filed: 2001-11-30
Abstract: Proporciona un compuesto de fórmula I, en el cual Ra, R1, R2, y R3 tienen los valores que se les atribuyen en la memoria descriptiva, así como derivados farmacéuticamente aceptables del mismo (incluyendo profármacos), útiles como inhibidores competitivos ( o profármacos de los mismos) de proteasas similares a la tripsina tales como trombina, y por lo tanto , en particular, útiles para el tratamiento de trastornos en los cuales sea necesaria una inhibición de la trombina ( por ejemplo, trombosis ) o como anticoagulantes
Patent UY-27392-A1 (UY)
Title: Derivados del ácido indan acetico y su uso como agentes farmacéuticos, intermediarios, y método de preparación
Inventor: LOWE D
IPC: A61P39/06
Filed: 2002-07-23
Abstract: Esta invención se refiere a nuevos derivados del ácido indan acético que son útiles en el tratamiento de enfermedades como la diabetes, la obesidad, la hiperlipidemia, y la enfermedad ateroesclerótica. La invención se refiere. además, a intermediarios útiles en la preparación de derivados indan acéticos y a métodos de preparación.
Patent UY-29381-A1 (UY)
Title: Composiciones de fragancia que reducen o eliminan el mal olor, metodos relacionados y composiciones limpiadoras relacionadas-
Inventor: GAMBOGI JOAN
IPC: C11D3/50
Filed: 2006-02-15
Abstract: La invención se refiere a una composición de fragancia para controlar el mal olor de la cocina, a unos productos limpiadores y desodorantes de cocina que la comprenden, y a unos métodos para la reducción del mal olor que utilizan dicha composición, la composición de fragancia conteniendo por lo menos cuatro de los siguientes componentes: a. Decil aldehido o decanal b. Glicolato de alil amilo c. Acetato de cis-3-hexenilo d. Óxido de rosa e. Terpinoleno f. 2,4-dimetil-3-ciclohexeno-1-carbaldehido.